abilify mycite

Generic: aripiprazole

Labeler: otsuka america pharmaceutical, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name abilify mycite
Generic Name aripiprazole
Labeler otsuka america pharmaceutical, inc.
Dosage Form TABLET WITH SENSOR
Routes
ORAL
Active Ingredients

aripiprazole 2 mg/1

Manufacturer
Otsuka America Pharmaceutical, Inc.

Identifiers & Regulatory

Product NDC 59148-029
Product ID 59148-029_7abd35b0-bc63-45ea-953d-dca97582964b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA207202
Listing Expiration 2026-12-31
Marketing Start 2018-01-31

Pharmacologic Class

Established (EPC)
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59148029
Hyphenated Format 59148-029

Supplemental Identifiers

RxCUI
1998451 1998453 1998454 1998455 1998456 1998457 1998458 1998459 1998460 1998461 1998462 1998463
UNII
82VFR53I78
NUI
N0000175430

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abilify mycite (source: ndc)
Generic Name aripiprazole (source: ndc)
Application Number NDA207202 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 KIT (59148-029-61) / 30 TABLET WITH SENSOR in 1 BOTTLE (59148-029-13)
  • 1 BOTTLE in 1 KIT (59148-029-72) / 30 TABLET WITH SENSOR in 1 BOTTLE (59148-029-13)
source: ndc

Packages (2)

Ingredients (1)

aripiprazole (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7abd35b0-bc63-45ea-953d-dca97582964b", "openfda": {"nui": ["N0000175430"], "unii": ["82VFR53I78"], "rxcui": ["1998451", "1998453", "1998454", "1998455", "1998456", "1998457", "1998458", "1998459", "1998460", "1998461", "1998462", "1998463"], "spl_set_id": ["e8787c3f-5e41-42d1-8091-44b56346620f"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Otsuka America Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 KIT (59148-029-61)  / 30 TABLET WITH SENSOR in 1 BOTTLE (59148-029-13)", "package_ndc": "59148-029-61", "marketing_start_date": "20201219"}, {"sample": false, "description": "1 BOTTLE in 1 KIT (59148-029-72)  / 30 TABLET WITH SENSOR in 1 BOTTLE (59148-029-13)", "package_ndc": "59148-029-72", "marketing_start_date": "20201219"}], "brand_name": "Abilify MyCite", "product_id": "59148-029_7abd35b0-bc63-45ea-953d-dca97582964b", "dosage_form": "TABLET WITH SENSOR", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "59148-029", "generic_name": "ARIPIPRAZOLE", "labeler_name": "Otsuka America Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abilify MyCite", "active_ingredients": [{"name": "ARIPIPRAZOLE", "strength": "2 mg/1"}], "application_number": "NDA207202", "marketing_category": "NDA", "marketing_start_date": "20180131", "listing_expiration_date": "20261231"}